J Thorac Cardiovasc Surg 2009;137:1295-1296
© 2009 The American Association for Thoracic Surgery
Shelhigh bioprosthesis in active infective endocarditis
Michele Musci, MD,
Henryk Siniawski, MD, PhD,
Roland Hetzer, MD, PhD
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum Berlin, Berlin, Germany
| The first 20% of the full text of this article appears below. |
To the Editor:
A recent article by Carrel and colleagues1
deals with the deleterious outcome of patients who received No-React (Shelhigh, Inc, Union, NJ)–treated stentless valved conduits. Seven (6.1%) of 115 patients presented with sudden disastrous findings at the level of the aortic root, and 4 of them underwent emergency operations because of disintegration of the graft along with rupture of the aortic root. The authors reported that retrospectively the main findings were persistent fever or subfebrility over months. They . . . [Full Text of this Article]
Copyright © 2009 by The American Association for Thoracic Surgery.